The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin

Antiviral Research

Volumn 64, Issue 1, 2004, Pages 47-53

  Dai, Chia Yen ^a,b   Chuang, Wan Long ^a   Chang, Wen Yu ^a   Chen, Shinn Cherng ^a   Lee, Li Po ^a   Lin, Zu Yau ^a   Hou, Nei Jen ^a,b   Hsieh, Ming Yuh ^a   Wang, Liang Yen ^a   Yu, Ming Lung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Combination therapy; HCV; Interferon; Ribavirin; SENV H

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; AGED; ARTICLE; DRUG MEGADOSE; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TAIWAN; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; AGED; ANTIVIRAL AGENTS; BASE SEQUENCE; CIRCOVIRIDAE; CIRCOVIRIDAE INFECTIONS; DNA, VIRAL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; RIBAVIRIN; TAIWAN; VIREMIA;

HEPATITIS C VIRUS;

EID: 4644278597     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.05.003     Document Type: Article

References (32)

1. Alter M.J., Margolis H.S., Krawczynski K., Judson F.N., Mares A., Alexander W.J., Hu P.Y., Miller J.K., Gerber M.A., Sampliner R.E. The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327:1992;1899-1905
2. Alter M.J., Gallagher M., Morris T.T., Moyer L.A., Meeks E.L., Krawczynski K., Kim J.P., Margolis H.S. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N. Engl. J. Med. 336:1997;741-746
3. Bowden S. New hepatitis viruses: contenders and pretenders. J. Gastroenterol. Hepatol. 16:2001;124-131
4. Chen D.S., Wang J.T., Chen P.J., Wan T.H., Sung J.L. Hepatitis C virus infection in Taiwan. Gastroenterol. Jpn. 26(Suppl. 3):1991;164-166
5. Chuang W.L., Chang W.Y., Lu S.N., Lin Z.Y., Chen S.C., Hsieh M.Y., Wang L.Y., You S.L., Chen C.J. The role of hepatitis C virus in chronic hepatitis B virus infection. Gastroenterol. Jpn. 28(Suppl. 5):1993;23-27
6. Dai C.Y., Yu M.L., Chuang W.L., Lin Z.Y., Chen S.C., Hsieh M.Y., Wang L.Y., Tsai J.F., Chang W.Y. Clinical characteristics and distribution of genotypes of TT virus infection in an HCV-hyperendemic township of an HBV-endemic country (Taiwan). J. Gastroenterol. Hepatol. 17:2002;1192-1197
7. Dai C.Y., Yu M.L., Chuang W.L., Sung M.H., Lin Z.Y., Chen S.C., Hsieh M.Y., Wang L.Y., Tsai J.F., Chang W.Y. Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan. Nephron. 90:2002;148-153
8. Dai C.Y., Yu M.L., Chen S.C., Lin Z.U., Hsieh M.Y., Lee L.P., Hou N.J., Hsieh M.Y., Wang L.Y., Tsai J.F., Chuang W.L., Chang W.Y. Clinical significance of TT Virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers. Hepatol. Res. 27:2003;95-100
9. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520
10. Kao J.H., Chen W., Chen P.J., Lai M.Y., Chen D.S. TT virus infection in patients with chronic hepatitis B or C: influence on clinical, histological and virological features. J. Med. Virol. 60:2000;387-392
11. Kao J.H., Chen W., Chen P.J., Lai M.Y., Chen D.S. Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan. J. Infect. Dis. 185:2002;389-392
12. Kao J.H., Chen W., Chen P.J., Lai M.Y., Chen D.S. SEN virus infection in patients with chronic hepatitis C: preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin. J. Infect. Dis. 187:2003;307-310
13. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W., Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435
14. Kobayashi N., Tanaka E., Umemura T., Matsumoto A., Iijima T., Higuchi M., Hora K., Kiyosawa K. Clinical significance of SEN virus infection in patients on maintenance haemodialysis. Nephrol. Dial. Transplant. 18:2003;348-352
15. Lai M.Y., Kao J.H., Yang P.M., Wang J.T., Chen P.J., Chan K.W., Chu J.S., Chen D.S. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology. 111:1996;1307-1312
16. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 345:2001;41-52
17. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., Goodman Z.D., Ling M.H., Cort S., Albrecht J.K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:1998;1485-1492
18. Mushahwar I.K. Recently discovered blood-borne viruses: are they hepatitis viruses or merely endosymbionts? J. Med. Virol. 62:2000;399-404
19. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 241:1997;92-97
20. Okamoto H., Tokita H., Sakamoto M., Horikita M., Kojima M., Iizuka H., Mishiro S. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J. Gen. Virol. 74:1993;2385-2390
21. Poynard T., Marcellin P., Lee S.S., Niederau C., Minuk G.S., Ideo G., Bain V., Heathcote J., Zeuzem S., Trepo C., Albrecht J. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet. 352:1998;1426-1432
22. Rigas B., Hasan I., Rehman R., Donahue P., Wittkowski K.M., Lebovics E. Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C. Lancet. 358:2001;1961-1962
23. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13:1991;372-374
24. Schröter M., Laufs R., Zöllner B., Knödler B., Schäfer P., Sterneck M., Fischer L., Feucht H.H. Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany. J. Viral. Hep. 9:2002;455-459
25. Shibata M., Wang R.Y., Yoshiba M., Shih J.W., Alter H.J., Mitamura K. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J. Infect. Dis. 184:2001;400-404
26. Simons J.N., Leary T.P., Dawson G.J., Pilot-Matias T.J., Muerhoff A.S., Schlauder G.G., Desai S.M., Mushahwar I.K. Isolation of novel virus-like sequences associated with human hepatitis. Nat. Med. 1:1995;564-569
27. Tanaka Y., Primi D., Wang R.Y., Umemura T., Yeo A.E., Mizokami M., Alter H.J., Shih J.W. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J. Infect. Dis. 183:2001;359-367
28. Umemura T., Yeo A.E., Sottini A., Moratto D., Tanaka Y., Wang R.Y., Shih J.W., Donahue P., Primi D., Alter H.J. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology. 33:2001;1303-1311
29. Umemura T., Alter H.J., Tanaka E., Yeo A.E., Shih J.W., Orii K., Matsumoto A., Yoshizawa K., Kiyosawa K. Association between SEN virus infection and hepatitis C in Japan. J. Infect. Dis. 145:2001;1246-1251
30. Umemura T., Alter H.J., Tanaka E., Orii K., Yeo A.E., Shih J.W., Matsumoto A., Yoshizawa K., Kiyosawa K. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C. Hepatology. 35:2002;953-959
31. Wang J.H., Lu S.N., Wu J.C., Huang J.F., Yu M.L., Chen S.C., Chuang W.L. A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. Trans. R. Soc. Trop. Med. Hyg. 93:1999;1-2
32. Yu M.L., Chuang W.L., Dai C.Y., Lu S.N., Wang J.H., Huang J.F., Chen S.C., Lin Z.Y., Hsieh M.Y., Tsai J.F., Wang L.Y., Chang W.Y. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area. J. Infect. 42:2001;61-66